Gene · 6788
Papers1,840
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
41 to 60 of 1,840
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Single-Cell RNA Sequencing Reveals LEF1-Driven Wnt Pathway Activation as a Shared Oncogenic Program in Hepatoblastoma and Medulloblastoma. | Curr Oncol | 2025 | 39851951 | PubTator, text mining | PubMed |
| CDK5 interacts with MST2 and modulates the Hippo signalling pathway. | FEBS Open Bio | 2025 | 39739588 | PubTator, text mining | PubMed |
| MST1 interactomes profiling across cell death in esophageal squamous cell carcinoma. | Med Rev (2021) | 2024 | 39664081 | PubTator, text mining | PubMed |
| Toxoplasma gondii induces MST2 phosphorylation mediating the activation of hippo signaling pathway to promote apoptosis and lung tissue damage. | iScience | 2024 | 39640582 | PubTator, text mining | PubMed |
| Exploring STK3 in melanoma: a systematic review of signaling networks and therapeutic opportunities. | Mol Biol Rep | 2024 | 39576434 | PubTator, text mining | PubMed |
| The long noncoding RNA ELFN1-AS1 promotes gastric cancer growth and metastasis by interacting with TAOK1 to inhibit the Hippo signaling pathway. | Cell Death Discov | 2024 | 39528458 | PubTator, text mining | PubMed |
| The molecular consequences of FOXF1 missense mutations associated with alveolar capillary dysplasia with misalignment of pulmonary veins. | J Biomed Sci | 2024 | 39497128 | PubTator, text mining | PubMed |
| Differential regulation of expression of the protein kinases DYRK1A and DYRK1B in cancer cells. | Sci Rep | 2024 | 39397076 | PubTator, text mining | PubMed |
| Pan-cancer analysis of the prognostic and immunological role of hippo-YAP signaling pathway. | Discov Oncol | 2024 | 39333438 | PubTator, text mining | PubMed |
| Identification of a novel alternative splicing isoform of the Hippo kinase STK3/MST2 with impaired kinase and cell growth suppressing activities. | Oncogene | 2024 | 39174858 | PubTator, text mining | PubMed |
| YAP represses the TEAD-NF-κB complex and inhibits the growth of clear cell renal cell carcinoma. | Sci Signal | 2024 | 38954637 | PubTator, text mining | PubMed |
| Harnessing the potential of hydrogels for advanced therapeutic applications: current achievements and future directions. | Signal Transduct Target Ther | 2024 | 38945949 | PubTator, text mining | PubMed |
| Genetic association analysis in sugarcane (Saccharum spp.) for sucrose accumulation in humid environments in Colombia. | BMC Plant Biol | 2024 | 38886648 | PubTator, text mining | PubMed |
| Scaffolding Supports the Hippo. | Cell Mol Gastroenterol Hepatol | 2024 | 38848765 | PubTator, text mining | PubMed |
| Characterization of PANoptosis-related genes and the immune landscape in moyamoya disease. | Sci Rep | 2024 | 38704490 | PubTator, text mining | PubMed |
| The choreography of chromatin in RNA polymerase III regulation. | Biochem Soc Trans | 2024 | 38666598 | PubTator, text mining | PubMed |
| Discovery and validation of molecular patterns and immune characteristics in the peripheral blood of ischemic stroke patients. | PeerJ | 2024 | 38650649 | PubTator, text mining | PubMed |
| The Hippo kinases control inflammatory Hippo signaling and restrict bacterial infection in phagocytes. | mBio | 2024 | 38624208 | PubTator, text mining | PubMed |
| STK3 higher expression association with clinical characteristics in intrinsic subtypes of breast cancer invasive ductal carcinoma patients. | Breast Cancer Res Treat | 2024 | 38592540 | PubTator, text mining | PubMed |
| MST2 Acts via AKT Activity to Promote Neurite Outgrowth and Functional Recovery after Spinal Cord Injury in Mice. | Mol Neurobiol | 2024 | 38581538 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6788/papers?page=3